Talking It Out: Perseverance Helps Sponsors Overcome Disagreements With FDA
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Some of the most valuable lessons learned out of Pharmaceutical Approvals Monthly’s Drug Review Profile series involve getting FDA to be flexible about what kind of clinical data it requires.